SANFORD BURNHAM PREBYS IMAGE: ZE’EV RONAI, PH.D. CREDIT: SANFORD BURNHAM PREBYS LA JOLLA, CALIF. – Sept 01, 2022 –Researchers at Sanford Burnham Prebys, led by Ze’ev Ronai, Ph.D., have shown for the first time that inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth. Published in Nature Cell Biology, these findings could lead to...
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER IMAGE: FROM LEFT TO RIGHT: FRANCESCA PUCA, PH.D., ANDREA VIALE, M.D., AND GIULIO DRAETTA, M.D., PH.D. CREDIT: MD ANDERSON CANCER CENTER HOUSTON – Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel function for the metabolic enzyme medium-chain acyl-CoA dehydrogenase (MCAD) in glioblastoma (GBM)....
